Oppenheimer & Co’s FT Vest US Equity Buffer ETF March FMAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$900K Sell
18,551
-7,526
-29% -$360K 0.01% 917
2025
Q4
$1.24M Sell
26,077
-88,916
-77% -$4.16M 0.02% 714
2025
Q3
$5.33M Sell
114,993
-276
-0.2% -$12.6K 0.07% 325
2025
Q2
$5.17M Buy
115,269
+484
+0.4% +$20.7K 0.07% 307
2025
Q1
$4.84M Buy
114,785
+95,841
+506% +$4.16M 0.07% 297
2024
Q4
$820K Buy
18,944
+894
+5% +$38.4K 0.01% 877
2024
Q3
$763K Buy
18,050
+678
+4% +$27.9K 0.01% 884
2024
Q2
$705K Sell
17,372
-563
-3% -$22.2K 0.01% 892
2024
Q1
$704K Sell
17,935
-81
-0.4% -$3.11K 0.01% 879
2023
Q4
$680K Buy
18,016
+66
+0.4% +$2.39K 0.01% 861
2023
Q3
$632K Sell
17,950
-349
-2% -$12.5K 0.01% 850
2023
Q2
$652K Sell
18,299
-2,104
-10% -$72.1K 0.01% 877
2023
Q1
$686K Buy
+20,403
New +$664K 0.01% 829

Other funds holding FMAR

Oppenheimer & Co's FMAR Position: Q1 2026 in Review

Oppenheimer & Co reduced its FT Vest US Equity Buffer ETF March (FMAR) stake by 29% in Q1 2026, selling an estimated $360K and leaving 18,551 shares worth $900K. The position accounts for 0.01% of the portfolio, ranked #917.

Oppenheimer & Co first reported a position in FMAR in Q1 2023 and has held it in 13 quarters since. The position peaked at $5.33M in Q3 2025. 132 funds tracked by Wall St. Rank hold FMAR as of Q1 2026.

  • Oppenheimer & Co held 18,551 shares of FT Vest US Equity Buffer ETF March worth $900K as of Q1 2026.
  • Oppenheimer & Co sold 7,526 FT Vest US Equity Buffer ETF March shares in Q1 2026, an estimated $360K.
  • FT Vest US Equity Buffer ETF March made up 0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #917 holding.
  • Oppenheimer & Co first reported a position in FT Vest US Equity Buffer ETF March in Q1 2023 and has held it in 13 quarters since.
  • Oppenheimer & Co's FT Vest US Equity Buffer ETF March position peaked at $5.33M in Q3 2025.
  • 132 funds tracked by Wall St. Rank held FT Vest US Equity Buffer ETF March as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.